| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |